AyuVis

Biopharma, Biotechnology, Pharmaceutical, Wellness
Founded in 1/1/14
Fort Worth, Texas, United States
http://www.ayuvis.com
For Profit

About AyuVis

AyuVis is a start-up biopharmaceutical company, developing a new class of immunotherapies to prevent and treat inflammation and infection. Its focus is on the development of the New Molecular Entities (NME)/ New Technologies as immune-modulating, anti-infective, and anti-inflammatory drugs. It is developing proprietary small molecule therapeutics, which have the potential to transform the treatment prospects for patients with life-threatening respiratory conditions including bronchopulmonary dysplasia, Pseudomonas aeruginosa pneumonia, cystic fibrosis, ARDS, COPD, and other inflammatory or infectious diseases. Suchismita Acharya founded the biotech company in 2014 and is based in Fort Worth, Texas.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 1800000 USD
  • Last Funding: 1800000 USD (Grant)
  • Funding Status:

Technology Stack

AyuVis actively uses None products in their tech stack.

Market Presence

Industries: Biopharma, Biotechnology, Pharmaceutical, Wellness

Headquarters: Fort Worth, Texas, United States

Employees

  • Suchismita Acharya - Chief Executive Officer (Primary employment) (LinkedIn)